in radiotherapy beam delivery using a head-mounted detector A beta - - PowerPoint PPT Presentation

in radiotherapy beam delivery
SMART_READER_LITE
LIVE PREVIEW

in radiotherapy beam delivery using a head-mounted detector A beta - - PowerPoint PPT Presentation

Real-time detection of deviations in radiotherapy beam delivery using a head-mounted detector A beta test of the IQM system in cooperation with Martijn Kusters PhD, Richard Canters PhD, Radboudumc, Nijmegen, The Netherlands Outline


slide-1
SLIDE 1

Real-time detection of deviations in radiotherapy beam delivery using a head-mounted detector

Martijn Kusters PhD, Richard Canters PhD, Radboudumc, Nijmegen, The Netherlands A beta test of the IQM system in cooperation with

slide-2
SLIDE 2

Outline

  • Current practice of treatment monitoring
  • The IQM system
  • Testing the IQM system
  • Discussion & Conclusions
slide-3
SLIDE 3

Current practice

Prescription Patient Dose

slide-4
SLIDE 4

Current practice

Errors in Delta 4 pre treatment QA Prescription

TPS

R&V

Linac

  • - Not always treatment linac

Transfer

  • - Not always treatment linac

Absolute dosimetry

  • - Not always treatment linac

Delivered beam

Dose in patient

slide-5
SLIDE 5

Solutions to monitor the delivered beam (and patient)

Monitor fluence from linac head Epid dosimetry

  • Relatively easy
  • Checks your linacs
  • Actual patient is

not monitored

  • Harder to implement and

more labour intensive

  • Actual delivered dose to the patient

can be made visible

slide-6
SLIDE 6

Error detection with in vivo monitoring

Errors in Delta 4 pre treatment QA Epid dosimetry Linac head monitor Prescription

  

TPS

  

R&V

  

Linac

  • - Not always treatment linac

 

Transfer

  • - Not always treatment linac

 

Absolute dosimetry

  • - Not always treatment linac

 

Delivered patient beam

  

Dose in patient

  

slide-7
SLIDE 7

Error detection with in vivo monitoring

Errors in Delta 4 pre treatment QA Prescription

TPS

R&V

Linac

  • - Not always treatment linac

Transfer

  • - Not always treatment linac

Absolute dosimetry

  • - Not always treatment linac

Delivered beam

Dose in patient

slide-8
SLIDE 8

The IQM system

Integral Quality Monitor Wedge shaped ionization chamber Signal dependent on:

  • Field/segment position
  • Field size and shape
  • Monitor units

Checksum

  • ne number, sensitive for

many parameters

   

Area field IQM

y x S I y x AOF MU C ) , ( ) , (

slide-9
SLIDE 9

Intended use of the IQM system

  • In vivo treatment monitoring
  • Realtime monitoring of beam delivery
  • Increased patient safety
  • Insight in the linac behaviour per

segment/control point

  • Pre-treatment QA
  • Can be run in between regular

treatments or whenever there is free time.

  • RTT’s can run the tests
  • Reduces a substantial effort in pre-

treatment QA

  • Possible to measure plans during 1st

fraction if not critical.

slide-10
SLIDE 10

Tests:error detection sensitivity

How well does IQM perform in intra-fractional detection?

  • Various IMRT and VMAT clinical beams,
  • Same beams with induced errors
  • One segment/control point retraction of leaves by 10, 5 and 2 mm
  • One segment increase of 10, 5 or 2 MU
  • Comparison to Delta4

5000 10000 15000 20000 25000 5 10 15 20 25 30

Checksum Segment Per segment checksum

50000 100000 150000 200000 250000 300000 5 10 15 20 25 30

Checksum Segment Cumulative checksum

slide-11
SLIDE 11

Testing the IQM system – detecting errors: one segment different MU

  • 10MU
  • 5MU
  • 2MU

10 10

1

10

2

10

  • 1

10 10

1

Maximum difference in segment signal [%] Maximum difference in cumulative signal [%]

IQM VMAT clinical VMAT modified 10 10

1

10

2

10

  • 1

10 10

1

Maximum difference in segment signal [%] Maximum difference in cumulative signal [%]

IQM VMAT clinical IMRT clinical VMAT modified IMRT modified 10 10

1

10

2

10

  • 1

10 10

1

Maximum difference in segment signal [%] Maximum difference in cumulative signal [%]

IQM VMAT clinical IMRT clinical VMAT modified IMRT modified VMAT clinical IMRT clinical VMAT modified IMRT modified

slide-12
SLIDE 12

Testing the IQM system – detecting errors: one segment leaf retraction

  • 10mm
  • 5mm
  • 2mm

10 10

1

10

2

10

  • 1

10 10

1

10

2

Maximum difference in segment signal [%] Maximum difference in cumulative signal [%]

IQM VMAT clinical IMRT clinical VMAT modified IMRT modified 10 10

1

10

2

10

  • 1

10 10

1

10

2

Maximum difference in segment signal [%] Maximum difference in cumulative signal [%]

IQM VMAT clinical IMRT clinical VMAT modified IMRT modified 10 10

1

10

2

10

  • 1

10 10

1

10

2

Maximum difference in segment signal [%] Maximum difference in cumulative signal [%]

IQM VMAT clinical IMRT clinical VMAT modified IMRT modified

slide-13
SLIDE 13

The ROC-curve

10 10

1

10

2

10

  • 1

10

Maximum difference in segment signal [%] Maximum difference in cumulative

VMAT modified IMRT modified

10090 80 70 60 50 40 30 20 10 0 10 20 30 40 50 60 70 80 90 100 Specificity [%] Sensitivity [%] Sensitivity/specificity 10090 80 70 60 50 40 30 20 10 0 10 20 30 40 50 60 70 80 90 100 Specificity [%] Sensitivity [%] Sensitivity/specificity 10090 80 70 60 50 40 30 20 10 0 10 20 30 40 50 60 70 80 90 100 Specificity [%] Sensitivity [%] Sensitivity/specificity

slide-14
SLIDE 14

Testing the IQM system – detecting errors

  • 10mm leaf retraction, 10MU
  • 2 mm, 2 MU

100 90 80 70 60 50 40 30 20 10 10 20 30 40 50 60 70 80 90 100 Specificity [%] Sensitivity [%] Sensitivity/specificity IQM Delta4 100 90 80 70 60 50 40 30 20 10 10 20 30 40 50 60 70 80 90 100 Specificity [%] Sensitivity [%] Sensitivity/specificity IQM Delta4 100 90 80 70 60 50 40 30 20 10 10 20 30 40 50 60 70 80 90 100 Specificity [%] Sensitivity [%] Sensitivity/specificity IQM Delta4

  • 5mm, 5MU
slide-15
SLIDE 15

Discussion & Conclusions

  • IQM enables realtime, intrafraction monitoring of beam delivery
  • Sensitivity and specificity can be expected to be sufficient for clinical

practice, and at least equal to our current equipment

  • Pre-treatment QA with IQM has the potential to save a lot of time, but has

yet to be tested

slide-16
SLIDE 16

Conclusions

Realtime monitoring with almost no user interaction

Prescription Patient Dose Calculate plan Checksum

Compare with measured checksum

Error detection well below clinically relevant limits